Trials / Completed
CompletedNCT00407524
AKL 1 Asthma Study
AKL1 Asthma Study - Randomised, Double-Blind, Placebo Controlled, Cross Over Study to Determine Safety and Efficacy of Oral AKL1 in Treating Patients With Asthma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (planned)
- Sponsor
- University of Aberdeen · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- —
Summary
This study aims to provide scientific evidence of the efficacy and safety of this agent as 'add-on' therapy for adult patients whose asthma remains uncontrolled on standard medication. The aims are to assess the efficacy, safety and tolerability of AKL 1 companred to placebo in the treatment of asthma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AKL 1 |
Timeline
- Start date
- 2003-10-01
- Completion
- 2005-03-01
- First posted
- 2006-12-05
- Last updated
- 2006-12-05
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00407524. Inclusion in this directory is not an endorsement.